DK328088A - Farmaceutisk komposition til behandling af tumorer - Google Patents

Farmaceutisk komposition til behandling af tumorer

Info

Publication number
DK328088A
DK328088A DK328088A DK328088A DK328088A DK 328088 A DK328088 A DK 328088A DK 328088 A DK328088 A DK 328088A DK 328088 A DK328088 A DK 328088A DK 328088 A DK328088 A DK 328088A
Authority
DK
Denmark
Prior art keywords
tumors
treatment
pharmaceutical composition
dipyridamole
interferon
Prior art date
Application number
DK328088A
Other languages
English (en)
Other versions
DK328088D0 (da
Inventor
Nobuo Suzuki
Yoshiaki Takakubo
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of DK328088D0 publication Critical patent/DK328088D0/da
Publication of DK328088A publication Critical patent/DK328088A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK328088A 1987-06-16 1988-06-15 Farmaceutisk komposition til behandling af tumorer DK328088A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87108708A EP0295317A1 (en) 1987-06-16 1987-06-16 Pharmaceutical composition for the treatment of tumors

Publications (2)

Publication Number Publication Date
DK328088D0 DK328088D0 (da) 1988-06-15
DK328088A true DK328088A (da) 1988-12-17

Family

ID=8197069

Family Applications (1)

Application Number Title Priority Date Filing Date
DK328088A DK328088A (da) 1987-06-16 1988-06-15 Farmaceutisk komposition til behandling af tumorer

Country Status (11)

Country Link
US (1) US4997645A (da)
EP (2) EP0295317A1 (da)
JP (1) JPS63316722A (da)
KR (1) KR890000108A (da)
AT (1) ATE59780T1 (da)
AU (1) AU622404B2 (da)
DE (1) DE3861494D1 (da)
DK (1) DK328088A (da)
HU (1) HU200942B (da)
PH (1) PH27069A (da)
ZA (1) ZA884262B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215744A (en) * 1987-06-16 1993-06-01 Boehringer Ingelheim Gmbh Methods for the treatment of tumors
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
US6003516A (en) * 1992-06-03 1999-12-21 Maxim Pharmaceuticals, Inc. Method for treatment of cancer and infectious disease
SE513429C2 (sv) * 1992-06-03 2000-09-11 Syntello Inc Preparat för aktivering av naturliga mördarceller, vilket preparat innehåller interferon alfa och biogena aminer
US5480640A (en) * 1995-05-02 1996-01-02 Schering Corporation Alpha interferon for treating prostate cancer
US6155266A (en) * 1995-05-08 2000-12-05 Maxim Pharmaceuticals, Inc. Method for treatment of cancer and infectious disease
US20020099003A1 (en) 1997-10-28 2002-07-25 Wilson Leland F. Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof
US7064130B2 (en) * 2001-04-20 2006-06-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders
WO2020065036A1 (en) * 2018-09-27 2020-04-02 Iteos Therapeutics S.A. Use of an inhibitor of an ent family transporter in the treatment of cancer and combination thereof with an adenosine receptor antagonist

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3031450A (en) * 1959-04-30 1962-04-24 Thomae Gmbh Dr K Substituted pyrimido-[5, 4-d]-pyrimidines
BG36086A1 (en) * 1982-01-19 1984-09-14 Glbov Method for inducing interferon

Also Published As

Publication number Publication date
AU622404B2 (en) 1992-04-09
EP0295559B1 (en) 1991-01-09
DE3861494D1 (de) 1991-02-14
JPH0529365B2 (da) 1993-04-30
US4997645A (en) 1991-03-05
EP0295559A2 (en) 1988-12-21
AU1768188A (en) 1988-12-22
EP0295559A3 (en) 1989-03-08
JPS63316722A (ja) 1988-12-26
PH27069A (en) 1993-02-01
ATE59780T1 (de) 1991-01-15
HUT47033A (en) 1989-01-30
DK328088D0 (da) 1988-06-15
KR890000108A (ko) 1989-03-11
EP0295317A1 (en) 1988-12-21
ZA884262B (en) 1990-02-28
HU200942B (en) 1990-09-28

Similar Documents

Publication Publication Date Title
DK33987D0 (da) Konserveringsblanding til trae
MX9203328A (es) Complejo de interferon de zinc-protamina-alfa.
DE3689363D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung der Metastasen von Krebstumoren.
DK162965C (da) Anvendelse af et difluornucleosid eller et farmaceutisk acceptabelt salt deraf til fremstilling af et laegemiddel til behandling af neoplasma
IT1139487B (it) Produzione microbica di interferone di fibroblasti umani
DK42490A (da) Melatoninanaloger
IT1223890B (it) Trattamento superficiale di refrattari
DK49488D0 (da) Anaestesi-praeparat
DK328088A (da) Farmaceutisk komposition til behandling af tumorer
DK0643973T3 (da) Anvendelse af humant interferon-beta til fremstilling af farmaceutiske præparater til behandling af kronisk myeloid leukæmi
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
DK159088A (da) Overfladebehandlingskompostition
IT8721560A0 (it) Procedimento per la purificazione di interferone.
ES2019634B3 (es) Terapia con clorfeniramina.
IT1159815B (it) Composizione medicinale per il trattamento di certe neurovirosi
ATE130194T1 (de) Subkutane verabreichung des humanen choriongonadotropins.
ATA120686A (de) Holzbehandlungskammer
IT1056810B (it) Procedimento per il trattamento di minerali di eoro calcio
FI863079A0 (fi) Kontinuerligt frigoerande fenyletanolaminderivatkompositioner.
DE3881991D1 (de) Zusammensetzung von gleitgliedern.
DE3382392D1 (de) Dosierungsart zur dauerhaften verabreichung von chinidin.
ATE87314T1 (de) Platin-arzneimittel.
GR3004272T3 (da)
IT8048117A0 (it) Composizione per il trattamento di infezioni virali e procedimento di preparazione
FI810760L (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1,4:3,6-dianhydro-2,5-diazido-2,5-dideoxihexitoler